Abstract
Transforming growth factor-beta (TGF-beta) is a cytokine of particular interest in human retrovirus infections because it can abrogate antigen-specific cellular activation. Although TGF-beta production has been observed in HIV infections, there is no evidence that herpes simplex virus (HSV)-stimulated human cells produce this cytokine. Here we present evidence, for the first time, that in vitro infection of human mononuclear cells with HSV type 1 (HSV-1) induced the release of TGF-beta1 protein. The production of this cytokine was time dependent and was found highly significant (p < 0.001) after 48 h. In addition, we observed that the secretion of TGF-beta1 was dependent on the concentration of human cells. It was found that virus needs to replicate in human cells for the production of TGF-beta1, as UV-inactivated virus did not induce significant production of cytokine protein. Interestingly, increased HSV-1-induced TGF-beta1 production in cultures containing antiinterleukin(IL)-12 or antiinterferon (IFN)-gamma antibodies was observed, whereas an irrelevant antibody had no effect on the production of this cytokine. Taken together, these findings indicate that human cells synthetize TGF-beta1 in response to HSV-1 and at the same time suggest that HSV-1-induced TGF-beta1 production may be one of the mechanisms by which HSV can at least partly evade activation of the host immune system.
Get full access to this article
View all access options for this article.